Clinical Trials Directory

Trials / Completed

CompletedNCT02000921

Reduced Nicotine Content Cigarettes and Tobacco Switching Behaviors

Models for Tobacco Productive Evaluation: Reduced Nicotine Content Cigarettes and Tobacco Switching Behaviors

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
136 (actual)
Sponsor
University of Minnesota · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The main focus of this study is to determine the use of nicotine-containing products across the three experimental conditions. Subjects will be monitored to determine their continued use of assigned cigarettes, switching to other combusted and/or non-combusted tobacco, or cessation of all tobacco containing products.

Detailed description

This is a single site, single-blind, randomized trial with three experimental conditions tested for a period of 8 weeks: 1) Very low nicotine content (VLNC) cigarettes (0.07 nicotine yield) with access to combusted (except cigarettes) and non-combusted tobacco and medicinal nicotine products; 2) VLNC cigarettes with access to only non-combusted tobacco and medicinal nicotine products; and 3) conventional nicotine (CN) content experimental cigarettes (0.8 mg nicotine) with access to combusted and non-combusted products. This study will examine the use of nicotine-containing products across the three experimental conditions. Subjects will be monitored to determine their continued use of assigned cigarettes, switching to other combusted (e.g., little cigars, large cigars, pipes) and/or non-combusted tobacco products (e.g., conventional smokeless tobacco, snus for smokers, dissolvables, e-cigarettes, medicinal nicotine), or cessation of all tobacco containing products. Toxicant exposure across the three conditions will also be examined. Eligible subjects will be provided very low nicotine content cigarettes and are told to use the product ad lib for 8 weeks. Subjects will complete questionnaires on demographics, smoking and health history, drug and alcohol use history, mood and perceptions of the study tobacco product. Biomarker samples will be analyzed for exposure levels of nicotine and tobacco-related toxicants.

Conditions

Interventions

TypeNameDescription
OTHERVLNC cigarettesModified risk tobacco product
OTHERCombusted ProductsOptions for combusted tobacco products include cigars, cigarillos, and little cigars, .
OTHERNon-combusted productsOptions for non-combusted tobacco products include smokeless tobacco, novel snus products, e-cigarettes and medicinal nicotine.
OTHERCN cigarettesExperimental cigarettes with conventional nicotine content.

Timeline

Start date
2013-12-01
Primary completion
2015-09-01
Completion
2016-09-01
First posted
2013-12-04
Last updated
2017-03-31
Results posted
2017-03-31

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02000921. Inclusion in this directory is not an endorsement.